HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CAM National Policy Advisory Board Proposed By White House Commission

This article was originally published in The Tan Sheet

Executive Summary

An advisory board addressing CAM policy would be assembled by the HHS Secretary within six months of receiving the White House CAM Commission's final recommendations under language currently included in the group's report

You may also be interested in...



ODS Methods, Reference Materials Program To Be Directed By AHPA’s Betz

Joseph Betz, PhD, is joining NIH's Office of Dietary Supplements to oversee a new program to facilitate development and validation of analytical methods and reference materials for dietary supplements

White House Commission To Advocate CAM Coordinating Office

The White House Commission on Complementary & Alternative Medicine Policy's interim report likely will propose the creation of a central office, possibly under the auspices of either HHS or the White House, to coordinate CAM activities and dialogue among federal agencies and the private sector.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS131948

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel